Activation of MIPEP Using CRISPR-Cas9 for Mitochondrial Stability and Telomere Preservation: A Novel In Silico Approach to Age-Related Type-II Diabetes Treatment and Ageing. JPEHSS 2025, 3 (3), 126-148. https://doi.org/10.63163/jpehss.v3i3.678.